Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 13 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $2.5M (5,220 shares) of United Therapeutics Corp on Dec 11, 2025. Filing
- Last sale before this period: Oct 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | EVP & General Counsel | Jan 5, 2004 | Oct 1, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, United Therapeutics Corp: sold 8,300 shares for $4.7M, under a disclosed plan; 8,300 shares acquired by exercising options. 1 filing: 1
- Sep 17, 2026, United Therapeutics Corp: sold 8,300 shares for $4.1M, under a disclosed plan; 8,300 shares acquired by exercising options. 1 filing: 1
- Sep 3, 2026, United Therapeutics Corp: sold 8,300 shares for $4.0M, under a disclosed plan; 8,300 shares acquired by exercising options. 1 filing: 1
- Aug 20, 2026, United Therapeutics Corp: sold 8,300 shares for $4.3M, under a disclosed plan; 8,300 shares acquired by exercising options. 1 filing: 1
- Aug 6, 2026, United Therapeutics Corp: sold 8,300 shares for $4.3M, under a disclosed plan; 8,300 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.